Munaza Ijaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Munaza Ijaz has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Haya Yasin
Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman, United Arab Emirates
3 shared publications Abida Kalsoom Khan
Department of Chemistry , COMSATS University Islamabad, Abbottabad Campus , Abbottabad , Pakistan
1 shared publication- Akram Ashames
Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman, United Arab Emirates
1 shared publication Badriyah Shadid Alotaibi
Department of Pharmaceutical Sciences, College of Pharmacy , Princess Nourah bint Abdulrahman University , P.O. Box 84428, Riyadh 11671 , Saudi Arabia
1 shared publication- Ghulam Murtaza
Department of Pharmacy, COMSATS University of Islamabad
1 shared publication - Hafiza Sidra Yaseen
Faculty of Pharmaceutical Sciences, Government College University Faisalabad, Faisalabad, Pakistan
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by Walter de Gruyter GmbH in Green Processing and Synthesis
- Vol. 14 (1)
Integration of traditional medicinal plants with polymeric nanofibers for wound healing
Chronic wounds pose a significant healthcare challenge, necessitating innovative approaches for improved healing. Traditional medicinal plants have long been used for wound care, and recent advancements in nanotechnology offer new possibilities for enhancing their therapeutic effects. Electrospun nanofibers provide an efficient drug delivery system, improving the bioavailability and stability of bioactive compounds. This review explores the integration of phytochemical-loaded nanofibers for wound healing, highlighting their potential in treating various wounds, including burns, diabetic ulcers, and surgical wounds. Additionally, it discusses the medicinal value of traditional plants, their role in wound care, and the future prospects of combining nanotechnology with artificial intelligence for personalized treatment.
- 1 January 2025
- Published by Walter de Gruyter GmbH in Green Processing and Synthesis
- Vol. 14 (1)
Open AccessIntegration of traditional medicinal plants with polymeric nanofibers for wound healing
Chronic wounds pose a significant healthcare challenge, necessitating innovative approaches for improved healing. Traditional medicinal plants have long been used for wound care, and recent advancements in nanotechnology offer new possibilities for enhancing their therapeutic effects. Electrospun nanofibers provide an efficient drug delivery system, improving the bioavailability and stability of bioactive compounds. This review explores the integration of phytochemical-loaded nanofibers for wound healing, highlighting their potential in treating various wounds, including burns, diabetic ulcers, and surgical wounds. Additionally, it discusses the medicinal value of traditional plants, their role in wound care, and the future prospects of combining nanotechnology with artificial intelligence for personalized treatment.
- Open Access
- 16 August 2024
- Published by Korean Society for Microbiology and Biotechnology in Journal of Microbiology and Biotechnology
- Vol. 34 (10) , 1981-1987
Evaluation and Molecular Characterization of Colistin-Resistant Isolates of Pseudomonas aeruginosa and Klebsiella pneumoniae from the Infected Wounds of Hospitalized Patients
Munaza Ijaz, Madiha Khan , and Haya Yasin. J. Microbiol. Biotechnol. 2024;34:1-7. https://doi.org/10.4014/jmb.2407.07005
- 16 August 2024
- Published by Korean Society for Microbiology and Biotechnology in Journal of Microbiology and Biotechnology
- Vol. 34 (10) , 1981-1987
Open AccessEvaluation and Molecular Characterization of Colistin-Resistant Isolates of Pseudomonas aeruginosa and Klebsiella pneumoniae from the Infected Wounds of Hospitalized Patients
Munaza Ijaz, Madiha Khan , and Haya Yasin. J. Microbiol. Biotechnol. 2024;34:1-7. https://doi.org/10.4014/jmb.2407.07005
- Open Access
In Vivo Wound Healing Potential and Molecular Pathways of Amniotic Fluid and Moringa Olifera-Loaded Nanoclay Films
Cutaneous wounds pose a significant health burden, affecting millions of individuals annually and placing strain on healthcare systems and society. Nanofilm biomaterials have emerged as promising interfaces between materials and biology, offering potential for various biomedical applications. To explore this potential, our study aimed to assess the wound healing efficacy of amniotic fluid and Moringa olifera-loaded nanoclay films by using in vivo models. Additionally, we investigated the antioxidant and antibacterial properties of these films. Using a burn wound healing model on rabbits, both infected and non-infected wounds were treated with the nanoclay films for a duration of twenty-one days on by following protocols approved by the Animal Ethics Committee. We evaluated wound contraction, proinflammatory mediators, and growth factors levels by analyzing blood samples. Histopathological changes and skin integrity were assessed through H&E staining. Statistical analysis was performed using SPSS software (version 2; Chicago, IL, USA) with significance set at p < 0.05. Our findings demonstrated a significant dose-dependent increase in wound contraction in the 2%, 4%, and 8% AMF-Me.mo treatment groups throughout the study (p < 0.001). Moreover, macroscopic analysis revealed comparable effects (p > 0.05) between the 8% AMF-Me.mo treatment group and the standard treatment. Histopathological examination confirmed the preservation of skin architecture and complete epidermal closure in both infected and non-infected wounds treated with AMF-Me.mo-loaded nanofilms. RT-PCR analysis revealed elevated concentrations of matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF), along with decreased levels of tumor necrosis factor-alpha (TNF-α) in AMF-Me.mo-loaded nanofilm treatment groups. Additionally, the antimicrobial activity of AMF-Me.mo-loaded nanofilms contributed to the decontamination of the wound site, positioning them as potential candidates for effective wound healing. However, further extensive clinical trials-based studies are necessary to confirm these findings.
Open AccessIn Vivo Wound Healing Potential and Molecular Pathways of Amniotic Fluid and Moringa Olifera-Loaded Nanoclay Films
Cutaneous wounds pose a significant health burden, affecting millions of individuals annually and placing strain on healthcare systems and society. Nanofilm biomaterials have emerged as promising interfaces between materials and biology, offering potential for various biomedical applications. To explore this potential, our study aimed to assess the wound healing efficacy of amniotic fluid and Moringa olifera-loaded nanoclay films by using in vivo models. Additionally, we investigated the antioxidant and antibacterial properties of these films. Using a burn wound healing model on rabbits, both infected and non-infected wounds were treated with the nanoclay films for a duration of twenty-one days on by following protocols approved by the Animal Ethics Committee. We evaluated wound contraction, proinflammatory mediators, and growth factors levels by analyzing blood samples. Histopathological changes and skin integrity were assessed through H&E staining. Statistical analysis was performed using SPSS software (version 2; Chicago, IL, USA) with significance set at p < 0.05. Our findings demonstrated a significant dose-dependent increase in wound contraction in the 2%, 4%, and 8% AMF-Me.mo treatment groups throughout the study (p < 0.001). Moreover, macroscopic analysis revealed comparable effects (p > 0.05) between the 8% AMF-Me.mo treatment group and the standard treatment. Histopathological examination confirmed the preservation of skin architecture and complete epidermal closure in both infected and non-infected wounds treated with AMF-Me.mo-loaded nanofilms. RT-PCR analysis revealed elevated concentrations of matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF), along with decreased levels of tumor necrosis factor-alpha (TNF-α) in AMF-Me.mo-loaded nanofilm treatment groups. Additionally, the antimicrobial activity of AMF-Me.mo-loaded nanofilms contributed to the decontamination of the wound site, positioning them as potential candidates for effective wound healing. However, further extensive clinical trials-based studies are necessary to confirm these findings.
- Top Cited PapersOpen Access
- 1 February 2021
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 16, 1313-1330
Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives
Nanotechnology has been actively integrated as drug carriers over the last few years to treat various cancers. The main hurdle in the clinical management of cancer is the development of multidrug resistance against chemotherapeutic agents. To overcome the limitations of chemotherapy, the researchers have been developing technological advances for significant progress in the oncotherapy by enabling the delivery of chemotherapeutic agents at increased drug content levels to the targeted spots. Several nano-drug delivery systems designed for tumor-targeting are evaluated in preclinical and clinical trials and showed promising outcomes in cancerous tumors’ clinical management. This review describes nanocarrier’s importance in managing different types of cancers and emphasizing nanocarriers for drug delivery and cancer nanotherapeutics. It also highlights the recent advances in nanocarriers-based delivery systems, including polymeric nanocarriers, micelles, nanotubes, dendrimers, magnetic nanoparticles, solid lipid nanoparticles, and quantum dots (QDs). The nanocarrier-based composites are discussed in terms of their structure, characteristics, and therapeutic applications in oncology. To conclude, the challenges and future exploration opportunities of nanocarriers in chemotherapeutics are also presented.
- 1 February 2021
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 16, 1313-1330
Top Cited PapersOpen AccessNanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives
Nanotechnology has been actively integrated as drug carriers over the last few years to treat various cancers. The main hurdle in the clinical management of cancer is the development of multidrug resistance against chemotherapeutic agents. To overcome the limitations of chemotherapy, the researchers have been developing technological advances for significant progress in the oncotherapy by enabling the delivery of chemotherapeutic agents at increased drug content levels to the targeted spots. Several nano-drug delivery systems designed for tumor-targeting are evaluated in preclinical and clinical trials and showed promising outcomes in cancerous tumors’ clinical management. This review describes nanocarrier’s importance in managing different types of cancers and emphasizing nanocarriers for drug delivery and cancer nanotherapeutics. It also highlights the recent advances in nanocarriers-based delivery systems, including polymeric nanocarriers, micelles, nanotubes, dendrimers, magnetic nanoparticles, solid lipid nanoparticles, and quantum dots (QDs). The nanocarrier-based composites are discussed in terms of their structure, characteristics, and therapeutic applications in oncology. To conclude, the challenges and future exploration opportunities of nanocarriers in chemotherapeutics are also presented.